Drug
ursodeoxycholic acid (UDCA)
ursodeoxycholic acid (UDCA) is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
40%
Ph not_applicable
3
60%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(3)
Detailed Status
Completed3
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (40.0%)
N/A3 (60.0%)
Trials by Status
not_yet_recruiting120%
recruiting120%
completed360%
Recent Activity
1 active trials
Showing 5 of 5
recruitingnot_applicable
The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia
NCT07110987
not_yet_recruitingnot_applicable
UDCA to Prevent Post-TIPS Hepatic Encephalopathy
NCT07273734
completedphase_1
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
NCT01088607
completedphase_1
A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects
NCT02622685
completednot_applicable
Ursodeoxycholic Acid in Bariatric Surgery
NCT01548079
Clinical Trials (5)
Showing 5 of 5 trials
NCT07110987Not Applicable
The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia
NCT07273734Not Applicable
UDCA to Prevent Post-TIPS Hepatic Encephalopathy
NCT01088607Phase 1
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
NCT02622685Phase 1
A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects
NCT01548079Not Applicable
Ursodeoxycholic Acid in Bariatric Surgery
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5